TY - JOUR
T1 - Amelioration of Friend Virus Leukemia by Sequential Administration of Viral and Nonviral Interferon Inducers
AU - Barker, Anna D.
AU - Rheins, Melvin S.
AU - Wilson, Henry E.
N1 - Funding Information:
This investigation was supported in part by Institutional Grant 3007-F1 and Project 2879 from the American Cancer Society. 7 1971 137 3 981 987
PY - 1971/7
Y1 - 1971/7
N2 - This study was designed to test the effect of the sequential administration of a series of viral and nonviral inducers of interferon on the progression of Friend virus leukemia in DBA/2 mice. The inducers, Poly I:C, SV, statolon, and tilorone hydrochloride, were given at 6-day intervals following injection of Friend virus, beginning 7 days postinfection until the 25th day. Mean splenomegaly, hepatomegaly, virus titer, and interferon titer were monitored periodically during the treatment regimen. Mice dying from the leukemia were autopsied and their liver and spleen weights recorded. The treatment regimen used was successful in increasing mean survival time and in decreasing hepatomegaly and splenomegaly. Decreases in virus titer and splenomegaly were associated with increased interferon levels in the spleens of experimental animals following administration of Poly I:C, statolon, and tilorone hydrochloride, while an enhancement phenomenon was observed after inoculation of SV. The amelioration of established Friend's disease observed using this program of therapy seems to offer promise, but other combinations of inducers (viral and nonviral) and protracted periods of treatment must be explored.
AB - This study was designed to test the effect of the sequential administration of a series of viral and nonviral inducers of interferon on the progression of Friend virus leukemia in DBA/2 mice. The inducers, Poly I:C, SV, statolon, and tilorone hydrochloride, were given at 6-day intervals following injection of Friend virus, beginning 7 days postinfection until the 25th day. Mean splenomegaly, hepatomegaly, virus titer, and interferon titer were monitored periodically during the treatment regimen. Mice dying from the leukemia were autopsied and their liver and spleen weights recorded. The treatment regimen used was successful in increasing mean survival time and in decreasing hepatomegaly and splenomegaly. Decreases in virus titer and splenomegaly were associated with increased interferon levels in the spleens of experimental animals following administration of Poly I:C, statolon, and tilorone hydrochloride, while an enhancement phenomenon was observed after inoculation of SV. The amelioration of established Friend's disease observed using this program of therapy seems to offer promise, but other combinations of inducers (viral and nonviral) and protracted periods of treatment must be explored.
UR - http://www.scopus.com/inward/record.url?scp=0015095912&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0015095912&partnerID=8YFLogxK
U2 - 10.3181/00379727-137-35710
DO - 10.3181/00379727-137-35710
M3 - Article
C2 - 5105377
AN - SCOPUS:0015095912
SN - 0037-9727
VL - 137
SP - 981
EP - 987
JO - Proceedings of the Society for Experimental Biology and Medicine
JF - Proceedings of the Society for Experimental Biology and Medicine
IS - 3
ER -